A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 52
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PRL
Long Form : phosphatase of regenerating liver
No. Year Title Co-occurring Abbreviation
2020 A FRET-based screening method to detect potential inhibitors of the binding of CNNM3 to PRL2. CBS, FRET
2020 Excessive Mg2+ Impairs Intestinal Homeostasis by Enhanced Production of ATP and Reactive Oxygen Species. ROS
2020 The Oncogenic PRL Protein Causes Acid Addiction of Cells by Stimulating Lysosomal Exocytosis. ---
2019 Molecular function and biological importance of CNNM family Mg2+ transporters. ---
2019 Phosphatase of regenerating liver sensitizes MET to functional activation by hepatocyte growth factor. HGF
2018 High throughput in silico identification and characterization of Plasmodium falciparum PRL phosphatase inhibitors. ---
2018 Phosphatase of regenerating liver maintains cellular magnesium homeostasis. ---
2018 Physiological and oncogenic roles of the PRL phosphatases. ---
2018 Targeting phosphatases of regenerating liver (PRLs) in cancer. PRLs, PTP4A
10  2017 Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer. BFFS, CFFS, PC, PCDFS
11  2017 Keep it on the edge: The post-mitotic midbody as a polarity signal unit. ---
12  2017 Mutational Analysis of a Conserved Glutamate Reveals Unique Mechanistic and Structural Features of the Phosphatase PRL-3. PTP
13  2017 Therapeutic Targeting of Oncogenic Tyrosine Phosphatases. PTK, PTP, SHP2
14  2016 Identification of proteins suppressing the functions of oncogenic phosphatase of regenerating liver 1 and 3. FKBP8, SELPLG
15  2016 Localizing PRL-2 expression and determining the effects of dietary Mg(2+) on expression levels. ---
16  2016 Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase. ---
17  2016 Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3. ---
18  2015 Characterization of the protein tyrosine phosphatase PRL from Entamoeba histolytica. OMFP, PTP EhPRL
19  2014 Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver. SAR
20  2014 Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression. ---
21  2014 Phosphatase of regenerating liver 2 (PRL2) deficiency impairs Kit signaling and spermatogenesis. PRL2
22  2014 Protein tyrosine phosphatases as potential therapeutic targets. FAP-1, LMWPTP, LYP, MKP-1, PTPs, SHP2, STEP
23  2014 Reversible oxidation of PRL family protein-tyrosine phosphatases. Cys, PTP, ROS
24  2013 Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogene. ---
25  2013 Expression of phosphatase of regenerating liver family genes during embryogenesis: an evolutionary developmental analysis among Drosophila, amphioxus, and zebrafish. CNS
26  2013 RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901. GC, siRNA
27  2013 Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3. CTLs, MT
28  2013 Thioredoxin-related protein 32 (TRP32) specifically reduces oxidized phosphatase of regenerating liver (PRL). TRP32
29  2012 Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer. PTPs
30  2012 Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion. ERK, siRNA
31  2012 Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells. CRC, MMPs, siRNA
32  2011 Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy. COX-2, RT
33  2011 Increased expression of the PRL-3 gene in human oral squamous cell carcinoma and dysplasia tissues. OSCCs
34  2011 PRL-1 protein promotes ERK1/2 and RhoA protein activation through a non-canonical interaction with the Src homology 3 domain of p115 Rho GTPase-activating protein. GAP, SH3
35  2010 Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2. Egr, MDM2, Pirh2
36  2010 Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma. ICC, LNM
37  2010 PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. PCBP1, UTR
38  2010 PRL-3 phosphatase and cancer metastasis. ---
39  2008 A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage. ---
40  2008 Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma. ESCC, mRNA
41  2008 Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9. CRC, MLM, SLM
42  2008 PRL PTPs: mediators and markers of cancer progression. PTPs
43  2008 Targeting PTPs with small molecule inhibitors in cancer treatment. PTKs, PTPs
44  2008 [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation]. ---
45  2007 Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer. ---
46  2007 High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. ---
47  2007 Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration. ---
48  2007 PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells. FAK
49  2006 PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. PTPs
50  2005 Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases. mAb
51  2005 PRL phosphatases as potential molecular targets in cancer. ---
52  2004 Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. ---